FILGRASTIM

Course overview

FILGRASTIM IS A MEDICATION USED FOR THE MANAGEMENT AND TREATMENT OF NEUTROPENIA IN PATIENTS WITH MYELOSUPPRESSION FROM CHEMOTHERAPY OR RADIATION, WHICH INCREASES THE RISK OF INFECTION AND RELATED EVENTS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTIONS, CONTRAINDICATION, ADVERSE EFFECTS, AND OTHER IMPORTANT DETAILS OF FILGRASTIM AS IT PERTAINS TO MEMBERS OF THE INTERPROFESSIONAL TEAM IN CLINICAL PRACTICE IN THE MANAGEMENT OF NEUTROPENIA AND ITS CLINICAL SEQUELAE.